Novartis Articles
Heptares in up to $200 million deal with Novartis for StaR technology for drug leads against a GPCR target
13 October 2009
Novartis to pay up to $485 million for Paratek’s IV antibiotic
12 October 2009
Switzerland orders H1N1 vaccines from GSK and Novartis
12 October 2009
Good news for Novartis’s MS drug fingolimod
1 October 2009
“No Frills Drugs” push Pharma to look for a cure
30 September 2009
EMEA backs flu vaccines from GlaxoSmithKline and Novartis
25 September 2009
Will Swine Flu provide proving ground for vaccine adjuvants?
25 September 2009
BIO-Europe 2009: an opportunity to hunt for deals
25 September 2009
EU Commission clears proposed acquisition of EBEWE SP by Novartis
23 September 2009
Amgen’s pipeline boosted by new denosumab data
23 September 2009
Senior management change at France’s Ipsen as Claude Bertrand joins
22 September 2009
VEM agrees to sell Ratiopharm; large number of interested parties
19 September 2009
“Novartis aims big in COPD market,” say Zacks analysts
17 September 2009
US FDA approves vaccines for 2009 H1N1 influenza virus
16 September 2009
Changes predicted in renal cell carcinoma market leaders
15 September 2009
US court rejects Astellas’ appeal on generic immunosuppressants
14 September 2009
Fixed-dose antihypertensive cannot stem tide of patent expiries
4 September 2009
SkyePharma slumps on US delay for Flutiform
2 September 2009
UCB extends German cardio/diabetes deal with Novartis
29 August 2009
Novartis’ Femara “superior to tamoxifen in breast cancer”
20 August 2009
Patent protection for key blockbuster depression drugs will drive growth in Europe and Japan, but not USA, says DR report
18 August 2009
Novartis Multiple sclerosis drug Extavia cleared by US FDA
17 August 2009
Vectura $6m milestone payment for VR315 from Novartis
13 August 2009
Opexa stock quadruples on deal with Novartis
10 August 2009
Par Pharma starts shipping generic Miacalcin
9 June 2009
Aileron closes $40M financing
9 June 2009
Novartis gets Wellcome grant for typhoid vacc
5 June 2009
Novartis launches 1.5B-euro notes issue
4 June 2009
Japan stock market week to June 1, 2009
3 June 2009
Merieux planning to sell Shantha Biotech
3 June 2009
Novartis, Novo, Lilly, BI breach ABPI Code
1 June 2009
Swiss pharma calls for price row moratorium
1 June 2009
FDA grants full approval to B-MS' Sprycel
27 May 2009
Strong results for Novartis' COPD drug
26 May 2009
Novartis gets option to acquire Elixir
22 May 2009
Retail drug sales in year to March 2009
22 May 2009
Stock Commentary - Europe - week to May 18, 2009
21 May 2009
Novartis buys generics cancer firm for $1.2B
20 May 2009
Opsona gets further 3.3M euros funding
19 May 2009
Novartis gets FDA approval for OTC Prevacid
15 May 2009
Novartis names Jonathan Symonds deputy CFO
14 May 2009
Stock Commentary - Europe - week to may 11, 2009
14 May 2009
Tokai Pharma closes $22M funding
12 May 2009
Teva's 1st-qtr profit more than triples
6 May 2009
Watson seeking to market generic Enablex in USA; Novartis files patent infringement suit
30 April 2009
EVM meets EC and EMEA over swine flu
30 April 2009
Novartis/Intercell's Ixiaro cleared in Europe
28 April 2009
URCH study foresees more pharma mega-mergers
27 April 2009
Retail drug sales in year to February 2009
24 April 2009
Novartis' 1st-qtr 2009 results boosted by new products
24 April 2009
Vectura receives a $3.2M milestone
23 April 2009
PDI and Novartis terminate accord
23 April 2009
Stock Commentary - Europe - week to April 20, 2009
23 April 2009
Drugmakers spent $3M in Vermont
21 April 2009
Tennessee Rx spend falls over 66%
21 April 2009
Mumbai pharmacies end Novartis boycott
17 April 2009
Aclasta more effective than risedronate
14 April 2009
Pfizer increases Indian subsidiary investment
14 April 2009
Cubist up on Novartis $1.6B buy rumors
9 April 2009
Novartis' Coartem approved by FDA
9 April 2009
Stock Commentary - Europe - week to Aug 15
8 April 2009
French pharmacy sales up only 1.8% in 2008
6 April 2009
Retail drug sales in year to January 2009
3 April 2009
Recalled batches of Menjugate "were safe"
3 April 2009
Stock Commentary - Europe - week to mar 30, 2009
2 April 2009
Survey finds EU patient empowerment disparity
1 April 2009
Afinitor cleared in USA for advanced RCC
1 April 2009
Novartis' JE vacc Ixiaro approved in USA
1 April 2009
ASA404 trial starts enrolling in Japan
30 March 2009
MDRNA in licensing deal with Novartis
30 March 2009
Retail drug sales in year to December 2008
30 March 2009
Glivec gets CHMP nod for new indication
30 March 2009
Stiefel Labs viewing a sale of itself? WSJ
30 March 2009
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
